Candriam Equities L Biotech.C-H EUR Acc/ LU1120766206 /
NAV23/05/2024 | Diferencia-3.4200 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
---|---|---|---|---|
194.2700EUR | -1.73% | reinvestment | Equity Worldwide | Candriam ▶ |
Rendimiento mensual
ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2015 | - | 4.50 | 1.83 | -5.03 | 10.78 | 0.59 | 4.26 | -10.61 | -11.54 | 7.84 | 3.34 | 0.40 | +4.26% |
2016 | -23.30 | -4.50 | 3.68 | 3.70 | 5.38 | -8.64 | 12.35 | -2.51 | 3.83 | -12.88 | 9.14 | -3.00 | -20.47% |
2017 | 5.33 | 6.69 | -0.05 | 0.89 | -3.15 | 9.22 | 2.21 | 6.71 | 0.69 | -6.82 | -0.16 | 1.27 | +24.05% |
2018 | 6.44 | -4.86 | -2.41 | -3.43 | 4.27 | 0.55 | 4.17 | 3.82 | -2.27 | -14.27 | 3.77 | -8.62 | -14.03% |
2019 | 12.76 | 3.32 | -0.89 | -5.21 | -4.74 | 9.15 | -2.47 | -2.55 | -4.76 | 10.91 | 11.78 | 2.49 | +30.88% |
2020 | -5.47 | -1.64 | -5.49 | 12.16 | 9.41 | 1.19 | -3.05 | 0.74 | 0.56 | -2.77 | 9.29 | 2.82 | +17.10% |
2021 | 1.73 | -2.65 | -4.44 | 2.62 | -2.35 | 6.25 | -1.54 | 3.80 | -4.36 | 0.09 | -4.46 | 2.24 | -3.71% |
2022 | -10.71 | -1.69 | 5.75 | -7.90 | -4.17 | 3.06 | 4.53 | 1.25 | -2.38 | 6.14 | 5.87 | -3.28 | -5.21% |
2023 | 2.66 | -5.87 | 0.05 | 2.69 | -1.17 | 1.20 | -0.77 | -0.42 | -4.65 | -6.26 | 5.89 | 13.33 | +5.25% |
2024 | 1.37 | 1.17 | -0.16 | -6.40 | 3.80 | - | - | - | - | - | - | - | - |
Valores estimados
Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
---|---|---|---|---|---|
Volatilidad | 15.87% | 17.14% | 16.23% | 20.05% | 22.64% |
Índice de Sharpe | -0.32 | 1.66 | -0.05 | -0.16 | 0.11 |
El mes mejor | +13.33% | +13.33% | +13.33% | +13.33% | +13.33% |
El mes peor | -6.40% | -6.40% | -6.40% | -10.71% | -10.71% |
Pérdida máxima | -11.27% | -11.27% | -16.45% | -30.33% | -32.47% |
Rendimiento superior | +0.20% | - | +1.23% | -7.79% | -6.03% |
Todas las cotizaciones en EUR
Tramos
Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
---|---|---|---|---|---|
Candriam Equities L Biotechnolog... | reinvestment | 2,029.3600 | +6.16% | +10.12% | |
Candriam Equities L Biotech.C EU... | reinvestment | 216.7100 | +4.70% | - | |
Candriam Equities L Biotech.I-H ... | reinvestment | 2,032.9000 | +3.88% | +2.44% | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,186.5100 | +5.62% | +24.17% | |
Candriam Equities L Biotech.I GB... | reinvestment | 3,350.8601 | +3.68% | +20.80% | |
Candriam Equities L Biotech.R GB... | reinvestment | 351.4100 | +3.73% | +24.57% | |
Candriam Equities L Biotech.R EU... | reinvestment | 319.7600 | +5.67% | +26.71% | |
Candriam Equities L Biotech.R-H ... | reinvestment | 197.8500 | +1.41% | +0.72% | |
Candriam Equities L Biotech.V2 U... | reinvestment | 1,815.4800 | +6.41% | +12.88% | |
Candriam Equities L Biotech.N-H ... | reinvestment | 147.0600 | - | - | |
Candriam Equities L Biotech.N US... | reinvestment | 590.2400 | +4.83% | +7.94% | |
Candriam Equities L Biotech.I US... | reinvestment | 5,552.8198 | +6.06% | +9.73% | |
Candriam Equities L Biotech.C-H ... | reinvestment | 194.2700 | +3.02% | +1.95% | |
Candriam Equities L Biotech.R-H ... | reinvestment | 202.5900 | +3.91% | +4.46% | |
Candriam Equities L Biotech.R US... | reinvestment | 263.1400 | +6.14% | +12.03% | |
Candriam Equities L Biotechnolo... | reinvestment | 828.5400 | +5.22% | +9.31% | |
Candriam Equities L Biotechnolog... | paying dividend | 756.6900 | +5.19% | +9.20% |
Performance
Año hasta la fecha | -0.52% | ||
---|---|---|---|
6 Meses | +14.80% | ||
Promedio móvil | +3.02% | ||
3 Años | +1.95% | ||
5 Años | +35.14% | ||
10 Años | - | ||
Desde el principio | +29.51% | ||
Año | |||
2023 | +5.25% | ||
2022 | -5.21% | ||
2021 | -3.71% | ||
2020 | +17.10% | ||
2019 | +30.88% | ||
2018 | -14.03% | ||
2017 | +24.05% | ||
2016 | -20.47% | ||
2015 | +4.26% |